Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

Indications for allogeneic haematopoietic stem cell transplantation in adult acute lymphoblastic leukaemia

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Submit
Thanks for rating
There has been a problem, please refresh and try again.
Published: 24.05.19
Views: 275
Rating:

Dr Mark Litzow - Mayo Clinic, Rochester, USA

Dr Mark Litzow talks to ecancer at the European School of Haematology (ESH) meeting: International Conference on Acute Lymphoblastic Leukaemia about the novel indications for the use of an allogeneic haematopoietic stem cell transplantation (HSCT) for the treatment of acute lymphoblastic leukaemia (ALL).

He states that the use of a paediatric, intensive chemotherapy regimen is associated with better outcomes in young adults.

Dr Litzow also mentions the observation that patients with a negative MRD experienced better remission along with a more favourable outcome.

With these indications, along with additional genetic markers, he describes that a transplant may not be required for these patients.

ecancer's filming has been kindly supported by Amgen through the ecancer Global Foundation. ecancer is editorially independent and there is no influence over content.

Related videos

18.06.19

no rating
Cancer care in Latin America

follow us

Core Surgical Training


Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation